These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 36991240)

  • 1. Correction to: Comprehensive Profiling of Secreted Factors in the Cerebrospinal Fluid of Moyamoya Disease Patients.
    Abhinav K; Lee AG; Pendharkar AV; Bigder M; Bet A; Rosenberg-Hasson Y; Cheng MY; Steinberg GK
    Transl Stroke Res; 2024 Jun; 15(3):688. PubMed ID: 36991240
    [No Abstract]   [Full Text] [Related]  

  • 2. Comprehensive Profiling of Secreted Factors in the Cerebrospinal Fluid of Moyamoya Disease Patients.
    Abhinav K; Lee AG; Pendharkar AV; Bigder M; Bet A; Rosenberg-Hasson Y; Cheng MY; Steinberg GK
    Transl Stroke Res; 2024 Apr; 15(2):399-408. PubMed ID: 36745304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moyamoya disease-specific extracellular vesicle-derived microRNAs in the cerebrospinal fluid revealed by comprehensive expression analysis through microRNA sequencing.
    Ota S; Yokoyama K; Kanamori F; Mamiya T; Uda K; Araki Y; Wakabayashi T; Yoshikawa K; Saito R
    Acta Neurochir (Wien); 2023 Aug; 165(8):2045-2055. PubMed ID: 37079107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cerebrospinal fluid protein associated with moyamoya disease: report of three cases.
    Hojo M; Hoshimaru M; Miyamoto S; Taki W; Kikuchi H; Hashimoto N
    Neurosurgery; 1999 Jul; 45(1):170-3; discussion 173-4. PubMed ID: 10414582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temperature measurement of intracranial cerebrospinal fluid using diffusion tensor imaging after revascularization surgery in Moyamoya disease.
    Shibukawa S; Konta N; Niwa T; Miyati T; Yonemochi T; Yoshimaru D; Horie T; Kuroda K; Sorimachi T
    Magn Reson Imaging; 2023 Jun; 99():1-6. PubMed ID: 36608908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SEREX identification of the autoantibodies that are prevalent in the cerebrospinal fluid of patients with moyamoya disease.
    Kim J; Kim SK; Wang KC; Kim HY; Jeoung D
    Biotechnol Lett; 2004 Apr; 26(7):585-8. PubMed ID: 15168859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of nitric oxide metabolites in the cerebrospinal fluid of patients with moyamoya disease.
    Noda A; Suzuki Y; Takayasu M; Watanabe K; Takagi T; Hara M; Yoshida J
    Acta Neurochir (Wien); 2000; 142(11):1275-9; discussion 1279-80. PubMed ID: 11201643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of hepatocyte growth factor in cerebrospinal fluid and intracranial artery in moyamoya disease.
    Nanba R; Kuroda S; Ishikawa T; Houkin K; Iwasaki Y
    Stroke; 2004 Dec; 35(12):2837-42. PubMed ID: 15528455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive Urinary Biomarkers in Moyamoya Disease.
    Sesen J; Driscoll J; Moses-Gardner A; Orbach DB; Zurakowski D; Smith ER
    Front Neurol; 2021; 12():661952. PubMed ID: 33868159
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of cytokines in cerebrospinal fluid from patients with moyamoya disease.
    Yoshimoto T; Houkin K; Takahashi A; Abe H
    Clin Neurol Neurosurg; 1997 Oct; 99 Suppl 2():S218-20. PubMed ID: 9409441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cerebrospinal fluid in patients with moyamoya disease (spontaneous occlusion of the circle of Willis) contains high level of basic fibroblast growth factor.
    Takahashi A; Sawamura Y; Houkin K; Kamiyama H; Abe H
    Neurosci Lett; 1993 Oct; 160(2):214-6. PubMed ID: 8247356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of Proenkephalin 143-183 in Cerebrospinal Fluid in Moyamoya Disease.
    Yokoyama K; Maruwaka M; Yoshikawa K; Araki Y; Okamoto S; Sumitomo M; Kawamura A; Sakamoto Y; Shimizu K; Izumi T; Wakabayashi T
    World Neurosurg; 2018 Jan; 109():e446-e459. PubMed ID: 29030229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiological consideration of medullary streaks on FLAIR imaging in pediatric moyamoya disease.
    Suzuki H; Mikami T; Kuribara T; Yoshifuji K; Komatsu K; Akiyama Y; Ohnishi H; Houkin K; Mikuni N
    J Neurosurg Pediatr; 2017 May; 19(5):560-566. PubMed ID: 28291429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1H-NMR-based metabolomic analysis of cerebrospinal fluid from adult bilateral moyamoya disease: comparison with unilateral moyamoya disease and atherosclerotic stenosis.
    Jeon JP; Yun T; Jin X; Cho WS; Son YJ; Bang JS; Kang HS; Oh CW; Kim JE; Park S
    Medicine (Baltimore); 2015 May; 94(17):e629. PubMed ID: 25929894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of soluble adhesion molecules are elevated in the cerebrospinal fluid of children with moyamoya syndrome.
    Soriano SG; Cowan DB; Proctor MR; Scott RM
    Neurosurgery; 2002 Mar; 50(3):544-9. PubMed ID: 11841722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of Apolipoprotein-E and Apolipoprotein-J in Moyamoya Disease-A Proteome Analysis of Cerebrospinal Fluid.
    Kashiwazaki D; Uchino H; Kuroda S
    J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2981-2987. PubMed ID: 28843803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenic factors in moyamoya disease.
    Yoshimoto T; Houkin K; Takahashi A; Abe H
    Stroke; 1996 Dec; 27(12):2160-5. PubMed ID: 8969773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of cerebrospinal fluid levels of basic fibroblast growth factor in moyamoya and central nervous system disorders.
    Malek AM; Connors S; Robertson RL; Folkman J; Scott RM
    Pediatr Neurosurg; 1997 Oct; 27(4):182-9. PubMed ID: 9577971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid chromatography coupled to mass spectrometry metabolomic analysis of cerebrospinal fluid revealed the metabolic characteristics of moyamoya disease.
    Yu J; Chen T; Li X; Chen J; Wei W; Zhang J
    Front Neurol; 2024; 15():1298385. PubMed ID: 38426176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of internal carotid artery blood flow velocity to fluid challenge under general anesthesia in pediatric patients with moyamoya disease: A prospective observational study.
    Kim EH; Park JB; Kang P; Ji SH; Jang YE; Lee JH; Kim JT; Kim HS
    Paediatr Anaesth; 2022 Dec; 32(12):1330-1338. PubMed ID: 36164813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.